As of 2026-03-31, the Relative Valuation of Guardant Health Inc (GH) is (75.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 92.37 USD, the upside of Guardant Health Inc based on Relative Valuation is -181.4%.
The range of the Relative Valuation is (75.15) - (77.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 32.4x | 27.3x |
| Forward P/E multiples | 17.2x - 24.5x | 20.1x |
| Fair Price | (75.15) - (77.75) | (75.21) |
| Upside | -181.4% - -184.2% | -181.4% |
| Date | P/E |
| 2026-03-30 | -27.16 |
| 2026-03-27 | -26.66 |
| 2026-03-26 | -27.76 |
| 2026-03-25 | -27.28 |
| 2026-03-24 | -26.34 |
| 2026-03-23 | -26.77 |
| 2026-03-20 | -26.84 |
| 2026-03-19 | -28.07 |
| 2026-03-18 | -27.50 |
| 2026-03-17 | -27.97 |
| 2026-03-16 | -27.47 |
| 2026-03-13 | -26.94 |
| 2026-03-12 | -26.47 |
| 2026-03-11 | -27.74 |
| 2026-03-10 | -28.51 |
| 2026-03-09 | -28.74 |
| 2026-03-06 | -28.74 |
| 2026-03-05 | -29.17 |
| 2026-03-04 | -29.31 |
| 2026-03-03 | -29.40 |
| 2026-03-02 | -29.06 |
| 2026-02-27 | -29.59 |
| 2026-02-26 | -30.87 |
| 2026-02-25 | -30.02 |
| 2026-02-24 | -30.06 |
| 2026-02-23 | -29.75 |
| 2026-02-20 | -32.49 |
| 2026-02-19 | -33.52 |
| 2026-02-18 | -33.85 |
| 2026-02-17 | -33.75 |
| 2026-02-13 | -33.04 |
| 2026-02-12 | -32.38 |
| 2026-02-11 | -33.90 |
| 2026-02-10 | -33.10 |
| 2026-02-09 | -33.19 |
| 2026-02-06 | -32.09 |
| 2026-02-05 | -30.99 |
| 2026-02-04 | -33.45 |
| 2026-02-03 | -35.62 |
| 2026-02-02 | -36.21 |
| 2026-01-30 | -35.93 |
| 2026-01-29 | -34.81 |
| 2026-01-28 | -34.58 |
| 2026-01-27 | -36.11 |
| 2026-01-26 | -36.15 |
| 2026-01-23 | -36.16 |
| 2026-01-22 | -36.96 |
| 2026-01-21 | -36.47 |
| 2026-01-20 | -36.20 |
| 2026-01-16 | -35.34 |